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Treatment of Aspergillus fumigatuswith echinocandins such as caspofungin inhibits the synthesis of cell wall -1,3-glucan,
which triggers a compensatory stimulation of chitin synthesis. Activation of chitin synthesis can occur in response to sub-MICs
of caspofungin and to CaCl2 and calcofluor white (CFW), agonists of the protein kinase C (PKC), and Ca
2-calcineurin signaling
pathways. A. fumigatusmutants with the chs gene (encoding chitin synthase) deleted (Afchs) were tested for their response to
these agonists to determine the chitin synthase enzymes that were required for the compensatory upregulation of chitin synthe-
sis. Only theAfchsGmutant was hypersensitive to caspofungin, and all otherAfchsmutants tested remained capable of in-
creasing their chitin content in response to treatment with CaCl2 and CFW and caspofungin. The resulting increase in cell wall
chitin content correlated with reduced susceptibility to caspofungin in the wild type and allAfchsmutants tested, with the ex-
ception of theAfchsGmutant, which remained sensitive to caspofungin. In vitro exposure to the chitin synthase inhibitor, nik-
komycin Z, along with caspofungin demonstrated synergistic efficacy that was again AfChsG dependent. Dynamic imaging using
microfluidic perfusion chambers demonstrated that treatment with sub-MIC caspofungin resulted initially in hyphal tip lysis.
However, thickened hyphae emerged that formed aberrant microcolonies in the continued presence of caspofungin. In addition,
intrahyphal hyphae were formed in response to echinocandin treatment. These in vitro data demonstrate that A. fumigatus has
the potential to survive echinocandin treatment in vivo by AfChsG-dependent upregulation of chitin synthesis. Chitin-rich cells
may, therefore, persist in human tissues and act as the focus for breakthrough infections.
Cases of invasive aspergillosis are associated with high mortalityrates of around 70% to 90% in immunocompromised pa-
tients (1). The majority of these infections are caused by Aspergil-
lus fumigatus and Aspergillus lentulus (2–6), with the remaining
due to Aspergillus flavus (10%), Aspergillus niger (2%), and Asper-
gillus terreus (2%) (6–8). There are few antifungal agents that are
effective for treatment of invasive aspergillosis, and some classes of
antifungals that are effective against other fungal pathogens are
not able to control Aspergillus infections. In addition, recent case
histories have shown examples of emerging antifungal drug resis-
tance in Aspergillus clinical isolates (6, 9, 10) and associated skin
carcinomas in some patients treated with voriconazole (11). The
echinocandins have been shown to cause lysis of growing hyphal
tips but are considered to be fungistatic against molds (12). Be-
cause treatment with the echinocandins fails to completely inhibit
growth of Aspergillus species, it is difficult to determine clear end-
points for inhibition and accurate MICs (13). As a result, alterna-
tive methods, such as the minimum effective concentration
(MEC), have been introduced to determine the activity of echino-
candins against filamentous fungi. The MEC is defined as the low-
est drug concentration at which short, stubby, highly branched
hyphae are observed (13–17). Treatment of A. fumigatus with the
echinocandin, caspofungin, leads to lysis of hyphal tips that is a
result of inhibition of apical A. fumigatus Fks1 (AfFks1)—the tar-
geted -1,3-glucan synthase (12, 18). Although treatment with
caspofungin results in lysis of hyphal tips, viability staining has
shown that older subapical compartments of A. fumigatus hyphae
can remain viable after exposure to caspofungin (12).
Previously, treatment of Candida albicans with caspofungin
has been shown to lead to a compensatory increase in cell wall
chitin synthesis that results in restoration of cell wall integrity
(19). Candida tropicalis, Candida parapsilosis, and Candida guilli-
ermondii but not Candida glabrata also demonstrated compensa-
tory upregulation of chitin content in response to treatment with
caspofungin (20–22). In C. albicans, the protein kinase C (PKC),
high-osmolarity glycerol (HOG), and Ca2-calcineurin signaling
pathways all contribute to the regulation of transcriptional activa-
tion of chitin synthesis (23). In this organism, there are only four
Chs enzymes: Chs2 and Chs8 (class I), Chs1 (class II), and Chs3
(class IV). Treatment of C. albicans with a combination of CaCl2
and calcofluor white (CFW) stimulated the Ca2-calcineurin and
PKC signaling pathways, respectively, and led to a 3- to 4-fold
increase in chitin content. Strains of C. albicans that have elevated
chitin contents were less susceptible to caspofungin than cells with
wild-type chitin levels (19, 22, 24, 25).
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The A. fumigatus cell wall is comprised of 20% chitin, which is
synthesized by eight Chs enzymes: A. fumigatus ChsA (AfChsA),
AfChsB, AfChsC, AfChsD, AfCsmA (AfChsE), AfChsF, AfChsG,
and AfCsmB (2, 3, 26–29), which by sequence homology fall into
different classes and have been characterized extensively via the
analysis of single and multiple mutants. The class III and V to VII
chitin synthase enzymes are specific to filamentous fungi. Disrup-
tion of single chitin synthase genes to create AfchsA (class I),
AfchsB (class II), and AfchsC (class III) mutants resulted in
mild or no phenotypic growth effects compared to the wild type
(26, 29–31). In contrast, hyphae of theAfchsD (class VI) mutant
were shown to have an increase in chitin content, and theAfchsF
mutant had a 25% reduction in chitin compared to the wild type
(29). Disruption of the class V enzyme, AfcsmA, resulted in an
80% reduction in conidial chitin content (29), and disruption of
AfcsmA and AfcsmB (class VII) resulted in hypersensitivity to
caspofungin (28). The AfcsmA and AfcsmB mutants also had a
defect in conidiation that may be abrogated by growth in osmot-
ically stabilized media (28, 29, 32). A quadruple AfcsmA
AfcsmBAfchsFAfchsD mutant was significantly attenuated in
immunosuppressed mice (29). The AfchsG single mutant and a
quadruple AfchsA AfchsC AfchsB AfchsG mutant were hy-
perbranched and had reduced radial growth (26, 29). TheAfchsA
AfchsC AfchsB AfchsG mutant was also shown to have a re-
duction in conidiation, and conidia that were produced had a
disorganized melanin layer on the surface which was attached
loosely to the inner cell wall. AfChsG was also shown to be re-
quired for in vitro CHS enzyme activity and was involved in syn-
thesizing chitin in the conidial wall (29). However, the quadruple
AfchsA AfchsC AfchsB AfchsG mutant was as virulent as the
wild type in a murine model of pulmonary aspergillosis (29). The
double class III/class V AfchsG AfchsE mutant had a 50% re-
duction in chitin content compared to wild-type cells and a 95%
reduction in chitin synthase enzyme activity (31).
The aims of this work were to determine whether treatment of
A. fumigatus with agents that increased chitin content affected
susceptibility to caspofungin and to establish which Chs enzymes
were important for the chitin upregulation in response to caspo-
fungin. The data demonstrate that hyphae with high chitin could
survive caspofungin treatment and that this response was strongly
AfCHSG dependent.
MATERIALS AND METHODS
Strains, media, and growth conditions. A. fumigatus strains used in this
study are listed in Table 1. A. fumigatus strains were maintained on Sab-
ouraud dextrose (Sabdex) agar plates (1% mycological peptone [wt/vol],
4% glucose [wt/vol], and 2% agar [wt/vol]).
Antifungal agents. Cells were grown in RPMI 1640 supplemented
with the following inhibitors: 2 g/ml caspofungin (obtained from Ab-
erdeen Royal Infirmary Pharmacy) and 2 g/ml nikkomycin Z (Sigma-
Aldrich, United Kingdom), which were dissolved in sterile water. In some
experiments, A. fumigatus was pretreated by growing in Sabdex broth
containing 0.2 M CaCl2 and 100 g/ml CFW (Sigma-Aldrich, United
Kingdom) for 8 h at 37°C with shaking at 200 rpm to elevate the chitin
content of hyphal cells.
Caspofungin sensitivity testing on solid medium. Caspofungin was
incorporated into RPMI 1640 agar plates at 2g/ml and 4g/ml. In some
experiments, caspofungin was used in combination with 2 g/ml nikko-
mycin Z. A. fumigatus spores were collected and serially diluted to gener-
ate suspensions containing 1  106 to 1,000 spores/ml in sterile water.
Plates were inoculated with 3-l drops of each spore suspension and in-
cubated for 48 h at 37°C.
Antifungal susceptibility testing. MICs were determined by broth
microdilution testing using the CLSI (formerly NCCLS) guideline
M38-A2 for filamentous fungi (33). Drug concentrations ranged from
0.032g/ml to 16g/ml of caspofungin. Caspofungin was serially diluted
with sterile water in flat-bottomed 96-well plates.A. fumigatus spores were
collected from agar plates in phosphate-buffered saline (PBS) (Oxoid)
plus 0.1% Tween 80 (Sigma) and inoculated in 11 ml 2RPMI 1640, and
200l of culture was added to each well. Plates were incubated for 48 h at
37°C. After incubation, each well was mixed thoroughly and optical den-
sities were read in a VersaMax tunable microplate reader (Molecular De-
vices, CA, USA) at 405 nm.
Determination of dry weights of mycelia. Dry weights of wild-type
and Afchs mutants were determined after 24 h growth in RPMI 1640
broth alone or supplemented with 2g/ml caspofungin. After incubation,
cultures were collected and filtered through preweighed 0.45-m filters.
The filters containing A. fumigatus strains were dried at 80°C for 24 h and
were then pared to constant weight.
Fluorescence microscopy. After washing with sterile water to remove
any excess medium, samples were fixed in 10% (vol/vol) neutral buffered
formalin (Sigma-Aldrich, United Kingdom) and examined by phase dif-
ferential interference contrast (DIC) microscopy. Cells were stained with
25 g/ml CFW to visualize chitin. All samples were examined by fluores-
cence microscopy using a Zeiss AxioPlan 2 microscope. Images were re-
corded digitally using the OpenLAB system (OpenLAB v4.04; Improvi-
sion, Coventry, United Kingdom) using a Hamamatsu C4742-95 digital
camera (Hamamatsu Photonics, Hamamatsu, Japan).
Electronmicroscopy. Cultures were harvested by centrifugation, and
the pellets were fixed in 2.5% (vol/vol) glutaraldehyde in 0.1 M sodium
phosphate buffer (pH 7.3) for 24 h at 4°C. Samples were encapsulated in
3% (wt/vol) low melting point agarose prior to embedding in Spurr’s
resin following a 24-h processing schedule on a Lynx tissue processor
(secondary 1% OsO4 fixation, 1% uranyl acetate contrasting, ethanol de-
hydration, and infiltration with acetone/Spurr resin). Additional infiltra-
tion was provided under vacuum at 60°C before embedding in Taab em-
bedding capsules and polymerization of the resin at 60°C for 48 h. Survey
sections of 0.5 m thickness were stained with toluidine blue to identify
areas of optimal cell density. Ultrathin sections (60 nm) were then pre-
pared using a Diatome diamond knife on a Leica UC6 ultramicrotome
and stained with uranyl acetate and lead citrate for examination with a
Philips CM10 transmission microscope (FEI UK Ltd., Cambridge, United
Kingdom) and imaging with a Gatan BioScan 792 (Gatan UK, Abingdon,
United Kingdom).
Wheat germagglutinin-colloidal gold staining of cell wall chitin.To
examine chitin distribution in cell walls, transmission electron micros-
copy (TEM) thin sections were stained with the lectin wheat germ agglu-
tinin (WGA), which was conjugated to colloidal gold particles (34–36).
Unstained ultrathin sections were mounted on 300-mesh nickel grids
(Agar Scientific Ltd., Essex, United Kingdom) and labeled with 10 nm
WGA-colloidal gold particles (British Biocell International Ltd., Cardiff,
United Kingdom). All incubation steps were performed at room temper-
ature by placing the grids into drops of reagent on dental wax. The grids
were immersed for 1 h in WGA-gold which had been diluted 1:5 with
Tris-buffered saline (TBS). Nonspecific binding of colloidal gold was
TABLE 1 A. fumigatus strains used in this study
Strain Parental strain Genotype Source or reference no.
H-237 Wild type Clinical isolate
H-458 H-237 chsC 26
H-452 H-237 chsD 27
H-480 H-237 chsG 26
H-466 H-458 chsC chsB Unpublished
H-484 H-458 chsC chsG 31
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tested with a 1:10 dilution of goat anti-mouse F(ab=)2 conjugated to col-
loidal gold (British Biocell International Ltd., Cardiff, United Kingdom).
All grids were washed with drops and jet rinsing in TBS followed by dis-
tilled water (dH2O). Thin sections were poststained for 10 min with 5%
(wt/vol) aqueous uranyl acetate and with lead citrate for 4 min (37).
Time-lapse observations using microfluidics. The ONIX microflu-
idic perfusion system (CellASIC Corp., USA) was used to analyze the
dynamic responses of A. fumigatus cells when perfused with caspofungin-
supplemented medium. According to the manufacturer’s instructions,
the flow rate and exchanging solutions were controlled by pressure
(pounds per square inch [psi]) using the ONIX FG software v2.6. Spores
were diluted to 5  104 in Sabdex broth containing 5 g/ml CFW to
visualize chitin and applied to a microfluidics plate, Y04C (CellASIC
Corp., USA). Approximately 50 spores were loaded into each chamber.
Sabdex broth containing CaCl2 and CFW was consistently perfused
through the chamber with a flow rate of 4 lb/in2 (10 l/h) for 6 h. Then
cells were treated with 32 g/ml caspofungin for a further 6 h and grown
in fresh medium for 8 h. Cells in the chamber were observed using a
DeltaVision Core microscope (Image Solutions Ltd., Preston, United
Kingdom). All images were taken using a CoolSNAP camera (Photomet-
rics UK Ltd., London, United Kingdom). Image analysis was performed
using ImageJ v1.45 free software (http://rsbweb.nih.gov/ij/).
RESULTS
Morphological changes in A. fumigatus hyphae in response to
caspofungin treatment. The effect of caspofungin on the mor-
phology of single germlings of A. fumigatus that had been pre-
treated with CaCl2 and CFW (Fig. 1B) compared to its effect on
sham-treated controls was examined in real time using a micro-
fluidics system (Fig. 1A). Exposure of A. fumigatus to 32 g/ml
caspofungin, after pregrowth with or without CaCl2 and CFW,
resulted in bursting of hyphal tips (Fig. 1). After lysis of hyphal
tips, incidences of septum formation distal to the burst hyphal
apices were observed (Fig. 1). Removal of caspofungin from the
growth medium resulted in new apical growth of some of the burst
hyphae (Fig. 1). The microfluidics chambers were then perfused
with medium containing no drug. After 6 to 8 h, there was evi-
dence of septum formation and of intrahyphal growth within
dead cells (Fig. 1). Therefore, caspofungin induced tip lysis but did
not sterilize cultures and sporadic septation and hyphal growth
resumed in the continued presence of caspofungin.
Caspofungin treatment induces a compensatory increase in
chitin content in A. fumigatus. A. fumigatus conidia were germi-
nated for 12 h in RPMI 1640 with and without caspofungin. Chitin
levels were determined by staining hyphae with CFW and by mea-
suring cell wall chitin content by high-pressure liquid chromatog-
raphy (HPLC). Staining with CFW showed an increase in chitin in
A. fumigatus hyphae after treatment with caspofungin compared
to untreated controls (Fig. 2A), as reported previously (38, 39).
Treatment of A. fumigatus with caspofungin resulted in the for-
mation of short, stumpy, hyperbranched hyphae (Fig. 2A). Bio-
chemical measurement of chitin content demonstrated that hy-
phae treated with 2 g/ml caspofungin had a 2.5-fold increase in
their cell wall chitin compared to untreated controls (Fig. 2B). The
increase in chitin content of A. fumigatus germlings in response to
caspofungin treatment was also examined in real time using a
microfluidics perfusion system (Fig. 3). Treatment with caspofun-
gin led to an initial lysis of most of the hyphal tips (Fig. 3b).
However, following lysis of hyphal tips, an increase in chitin con-
tent within some hyphal regions distal to the sites of tip lysis was
observed that was coincident with the resumption of growth of
wide, hyperbranched hyphae (Fig. 3c). In some experiments, cul-
tures exhibiting this adapted growth phenotype were perfused
with 64 g/ml nikkomycin Z in combination with caspofungin,
but this did not inhibit growth (Fig. 3d).
Next, a series of Afchs disruption mutants was stained with
CFW to establish which CHS enzymes were required for the com-
pensatory increase in chitin synthesis induced by exposure to
caspofungin (Fig. 4i). Most untreatedAfchs mutants had similar
chitin content to the wild type, with the exception of the AfchsG
mutant, which exhibited swollen cells with high CFW staining
(Fig. 4i). Treatment with caspofungin resulted in a compensatory
increase in chitin content in the individual Afchs mutants com-
pared to untreated strains, with the exception of strains lacking
AfCHSG (Fig. 4ii).
Theclass III chitin synthase, encodedbyAfCHSG, is involved
in the synergistic action of caspofungin and nikkomycin Z.
Caspofungin has a fungistatic effect on the growth of A. fumiga-
tus and results in a compensatory increase in chitin synthesis (Fig.
2). Since chitin upregulation affected caspofungin efficacy, we as-
sessed whether combinations of chitin synthase inhibitors and
caspofungin acted synergistically. The addition of 2 g/ml of the
chitin synthase inhibitor nikkomycin Z did not affect growth on
FIG 1 Morphological changes in A. fumigatus in response to caspofungin. A. fumigatus spores were trapped in a microfluidics chamber and grown in Sabouraud
plus 2% glucose for 6 h in the absence (A) or presence (B) of CaCl2 and CFW. Then all cells were treated with 32 g/ml caspofungin for another 6 h and grown
in fresh medium for 8 h. Yellow arrowheads indicate intrahyphal hyphae. White arrowheads indicate newly formed septum. Scale bars 20 m.
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RPMI 1640 agar, whereas the addition of 2g/ml caspofungin led
to a dramatic reduction in colony size (Fig. 5A). Combined treat-
ment with caspofungin and nikkomycin Z resulted in the forma-
tion of colonies with substantially reduced radial growth com-
pared to treatment with caspofungin alone (Fig. 5A).
The sensitivity of the Afchs mutants to caspofungin was de-
termined. All of theAfchsmutants grew similarly to the wild type
on RPMI 1640 alone, with the exception of the AfchsG and
AfchsC AfchsG mutants, which were viable but had reduced
radial growth (Fig. 5B). Similarly, treatment with caspofungin led
to a reduction in colony diameter, and the inhibition of growth
was similar to wild-type cells for the majority of Afchs mutants
(Fig. 5B). Exceptions were the AfchsG and AfchsC AfchsG
mutants, which were hypersensitive to caspofungin (Fig. 5B).
Treatment with 2g/ml caspofungin alone led to a 50% reduction
in growth of wild-type cells, whereas treatment with 2 g/ml nik-
komycin Z alone led to a 30% reduction in growth (Fig. 5C).
Combined treatment of caspofungin and nikkomycin Z at the
same concentrations had an additive effect and resulted in a 75%
reduction in growth of wild-type cells (Fig. 5C). When grown in
RPMI 1640 alone, all Afchs mutants exhibited growth that was
comparable to the wild type, again with the exception of the
AfchsG andAfchsCAfchsG mutants, which had a 45% reduc-
tion in growth (Fig. 5C). Similarly, treatment of the Afchs mu-
tants with caspofungin resulted in a 35% reduction in growth that
was comparable to that of the wild type. Again the exception was the
AfchsG and AfchsC AfchsG mutants, which demonstrated an
80% to 90% reduction in growth in the presence of caspofungin (Fig.
5C). The reduction in growth of theAfchsG andAfchsCAfchsG
mutants in the presence of caspofungin was comparable to the reduc-
tion in growth observed when wild-type cells were treated with a
combination of caspofungin and nikkomycin Z (Fig. 5C). Therefore,
the class III chitin synthaseAfChsG was most critically involved in the
response to caspofungin treatment.
FIG 2 Treatment with caspofungin leads to a compensatory increase in chitin content in A. fumigatus. The wild-type strain was grown at 37°C for 12 h in RPMI
1640 in the presence and absence of 2g/ml caspofungin. (A) CFW-stained fluorescent images; scale bars are 10m. (B) Cell wall chitin assays were performed
three times on three biologically independent samples (average	 standard deviation [SD], n 9). The asterisk indicates significant difference (P
 0.05) from
untreated cells.
FIG 3 Intrahyphal growth of A. fumigatus corresponds to areas of increased chitin content in response to caspofungin treatment. A. fumigatus spores were
trapped in a microfluidics chamber and grown in Sabdex broth plus 2% glucose for 2 h. Cells were then treated with 32 g/ml caspofungin for 6 h, followed by
combination treatment with 32g/ml caspofungin and 64g/ml nikkomycin Z for a further 6 h. Yellow arrowheads indicate intrahyphal hyphae. DIC (top) and
CFW fluorescent images (bottom). Scale bars 10 m.
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Treatment with CaCl2 and CFW increases chitin content in
A. fumigatus. Previously, treatment with CaCl2 and CFW was
shown to increase the chitin content of C. albicans and reduce
susceptibility to caspofungin (19, 23). To determine whether
treatment with CaCl2 and CFW also increased the chitin content
of A. fumigatus, spores were germinated in Sabdex broth with and
without a combination of 200 mM CaCl2 and 100g/ml CFW for
8 h. Hyphae that had germinated in the presence of CaCl2 and
CFW had a 2-fold increase in cell wall chitin content, measured by
HPLC, compared to that of the wild type (Fig. 6A). Ultrastructural
analysis using transmission electron microscopy revealed that
CaCl2- and CFW-treated hyphae had 45% thicker cell walls
(Fig. 6Bii), which were chitin rich (Fig. 6Biv) relative to those of
untreated hyphae (Fig. 6Bi and Biii).
FIG 4 AfCHSG is required for the compensatory increase in chitin content in response to caspofungin treatment. CFW-stained fluorescent images of the
wild-type (WT) strain and Afchs mutants in RPMI 1640 alone (i) or supplemented with 2 g/ml caspofungin (ii) after 12 h at 37°C. Scale bars 10 m.
FIG 5 Disruption of AfCHSG leads to hypersensitivity to caspofungin. (A) Plate dilution sensitivity tests of the A. fumigatus wild-type strain on RPMI 1640 agar
alone (i) or supplemented with 2g/ml caspofungin (ii), 2g/ml nikkomycin Z (iii), or a combination (iv). (B) TheAfchs mutants were grown on RPMI 1640
agar with or without 2g/ml caspofungin. Plates were incubated for 48 h at 37°C. Spore numbers per spot are 5,000, 500, 50, and 5 spores, from left to right. (C)
Dry weights of wild-type and Afchs mutants were determined after 24 h growth in RPMI 1640 broth alone or supplemented with 2 g/ml caspofungin. The
wild-type strain was also treated with 2 g/ml nikkomycin Z alone and in combination with caspofungin. Error bars are SD (n  3, from three independent
experiments). Asterisks indicate significant differences (P
 0.05) from untreated cells of the same genetic background. #, significant difference (P
 0.05) from
the wild-type cells in the same growth conditions. Numbers represent percentages of growth inhibition compared to untreated cells of the same genetic
background.
Walker et al.
5936 aac.asm.org October 2015 Volume 59 Number 10Antimicrobial Agents and Chemotherapy
 o
n
 Septem
ber 23, 2015 by University of Aberdeen
http://aac.asm
.org/
D
ow
nloaded from
 
Afchs mutants were also treated with the CaCl2 and CFW
combinations, and their relative chitin contents were determined
by staining with 25 g/ml CFW. Treatment with CaCl2 and CFW
led to defined chitin-rich patches in all Afchs mutants at some
hyphal tips and at the kinks and bends of hyphal cells. The CFW-
rich patches were evident in multiple Afchs null mutants, sug-
gesting that no single CHS was responsible exclusively for the in-
crease in chitin content resulting from caspofungin exposure (Fig.
7). However, in the wild-type strain, there was a more uniform
increase in chitin staining along the hypha, perhaps indicating that
some differences exist between the mutants and the wild type in
the spatial deposition of chitin upon CaCl2 and CFW cotreatment.
Activation of the cell wall salvage pathway protects against
caspofungin treatment. To determine whether increased chitin
content leads to reduced caspofungin susceptibility in A. fumiga-
tus, conidia were first germinated in Sabdex broth with and with-
out 200 mM CaCl2 and 100 g/ml CFW to elevate chitin, then
hyphae were washed and exposed to caspofungin. Pregrowth with
CaCl2 and CFW enhanced the growth of the wild type andAfchs
mutants on control plates and led to reduced susceptibility to
caspofungin in all strains tested, with the exception of strains lack-
ing AfCHSG (Fig. 8). When strains lacking AfCHSG were grown
with CaCl2 and CFW prior to caspofungin treatment, the radial
growth of their colonies was still reduced compared to that of the
colonies grown without CaCl2 and CFW pretreatment (Fig. 8).
The caspofungin MECs for untreated and pretreated strains
were measured in liquid RPMI 1640. In most cases, pregrowth
with CaCl2 and CFW led to a significant reduction in susceptibility
to caspofungin (Table 2). Again, the exceptions were the AfchsG
and AfchsC AfchsG mutants, which retained their increased
susceptibility to caspofungin even after pregrowth with CaCl2 and
CFW. Therefore, AfCHSG was critical for the protective upregu-
lation of chitin synthesis in A. fumigatus.
DISCUSSION
We show here that exposure to the echinocandin caspofungin can
lead to the upregulation of chitin synthesis mediated by AfChsG
and subsequent survival and growth of aberrant chitin-rich hyper-
branched hyphae. The importance of these observations is that
this chitin-rich surviving biomass has the potential to act as a
reservoir for regrowth of Aspergillus mycelium following echino-
candin treatment.
Different species of Aspergillus have various susceptibilities to
the echinocandins, and several examples of echinocandin resis-
tance in Aspergillus species have been reported (17, 40–48).
Anidulafungin displays the greatest inhibition of growth across
theAspergillus spp. compared to that of caspofungin and micafun-
FIG 6 Treatment with CaCl2 and CFW increases A. fumigatus cell wall chitin.
The A. fumigatus wild-type strain (H237) was grown at 37°C for 8 h in Sabouraud
dextrose broth alone and supplemented with 200 mM CaCl2 or 100g/ml CFW or
a combination. (A) Cell wall chitin assays were performed three times on three
biologically independent samples (average 	 SD, n  9). An asterisk indicates
significant difference (P 
 0.05) from untreated cells. (B) TEM images of the
wild-type strain grown at 37°C for 8 h in Sabouraud dextrose broth alone (i) and
supplemented with 200 mM CaCl2 and 100g/ml CFW (ii). WGA-colloidal gold-
stained TEM sections showing chitin in untreated wild-type cells (iii) and wild-
type cells treated with CaCl2 and CFW (iv). Scale bars 0.2m.
FIG 7 Treatment with CaCl2 and CFW leads to an increase in chitin synthesis inAfchs mutants of A. fumigatus. CFW-stained fluorescent images of the wild-type
strain and Afchs mutants in Sabdex broth alone (A) or supplemented with 200 mM CaCl2 and 100 g/ml CFW (B) after 12 h at 37°C. Scale bars 10 m.
Response of Aspergillus fumigatus to Caspofungin
October 2015 Volume 59 Number 10 aac.asm.org 5937Antimicrobial Agents and Chemotherapy
 o
n
 Septem
ber 23, 2015 by University of Aberdeen
http://aac.asm
.org/
D
ow
nloaded from
 
gin. Generally, clinical isolates of A. fumigatus, A. terreus, and A.
flavushave been reported to have comparable susceptibilities to all
three echinocandins (43). In contrast, A. niger has been shown to
be considerably more susceptible to caspofungin (MEC, 0.1 to 0.5
g/ml) than A. fumigatus (MEC, 0.2 to 6g/ml), which is thought
to be due to differences in cell wall composition (17). Potential
mechanisms of resistance to caspofungin in A. fumigatus have
been highlighted by two classes of laboratory-generated mutants
that have reduced susceptibility to caspofungin (49). Point muta-
tions within AfFKS1 leading to an S678P amino acid substitution
resulted in an MEC of 4 g/ml, compared to an MEC of 0.25
g/ml with the susceptible wild-type strain (49, 50). This was
considered a low level of resistance, as the MEC was only 16-fold
higher. In contrast, spontaneous caspofungin-resistant mutants
that were generated by cell wall digestion, followed by regenera-
tion of spheroplasts on caspofungin-containing medium, dis-
played higher levels of resistance (49). Expression profiling of
these mutants after treatment with caspofungin showed upregu-
lation of genes involved in cell wall biosynthesis/remodelling,
structural cell components, and transport (49). In addition, a clin-
ical isolate of A. fumigatus from a patient who failed caspofungin
therapy was shown to be resistant due to overexpression of the
AfFKS1 gene (51). Two recent studies have also demonstrated that
clinical resistance to caspofungin in Aspergillus spp. occurred at a
frequency of 4% to 6% in cancer patients and transplant recipients
(40, 45). Furthermore, there have been several reports of the
emergence of anidulafungin-resistant molds in the clinic (40, 42,
44, 45).
In C. albicans and A. fumigatus, growth at high concentrations
above the MIC of caspofungin, termed paradoxical growth, has
been observed in vitro. Paradoxical growth occurs most com-
monly when A. fumigatus is treated with caspofungin, rather than
micafungin or anidulafungin, in vitro (38, 43). In C. albicans, cells
demonstrating paradoxical growth were shown to have a 900%
increase in chitin content, suggesting that the regrowth at high
concentrations of caspofungin was due to an increase in chitin
content (52). In A. fumigatus, addition of the calcineurin inhibi-
tor, FK506, or deletion of genes from the calcineurin pathway
abolished the occurrence of paradoxical growth (38). Rogg et al.
(53) demonstrated that the Ca2-calcineurin pathway was re-
quired for the transcriptional upregulation of AfCHSA and
AfCHSC in response to caspofungin treatment. Likewise, chitin
content and chitin synthase enzyme activity were also increased
during paradoxical growth (38). A likely hypothesis is therefore
that paradoxical effects arise because high levels of echinocandins
are able to activate the cell wall salvage pathway(s) that promote
chitin synthesis and cell survival.
The data presented here highlight the potential of increased
chitin content as a mechanism of reduced susceptibility to caspo-
fungin in A. fumigatus. Treatment of wild-type cells with caspo-
fungin resulted in a 2.5-fold compensatory increase in chitin con-
tent. This supports the findings of previous studies where a
different wild-type strain of A. fumigatus also demonstrated a
compensatory increase in chitin content in response to treatment
with all three echinocandins (21, 39). Here we show that disrup-
tion of the class II, III, and VI chitin synthase genes did not mark-
edly affect the ability of A. fumigatus to increase chitin synthesis to
compensate for the inhibition of -1,3-glucan synthesis by caspo-
fungin. Therefore, the remaining AfCHS genes may be deduced to
be able to compensate for the loss of the class II, III, and VI chitin
synthase enzymes by synthesizing sufficient chitin to protect the
fungus from caspofungin. Supporting this, combined treatments
of A. fumigatus with caspofungin and nikkomycin Z did not in-
hibit the compensatory increase in chitin content (21). The com-
pensatory increase in chitin content of A. fumigatus in response to
caspofungin treatment has also been shown to be dependent on
the A. fumigatus Ca2-calcineurin pathway genes AfCNAA and
AfCRZA (21).
In C. albicans, pregrowth of cells with a combination of CaCl2
and CFW activates the Ca2-calcineurin and PKC signaling path-
ways, resulting in a 3- to 4-fold increase in chitin content (23).
TABLE 2 Pretreatment with CaCl2 and CFW increases the caspofungin
MEC against A. fumigatus strains
A. fumigatus strain
description
MEC (g/ml)
Untreated
Pretreated (CaCl2
and CFW)
Wild type 0.5 4
chsC 0.5 4
chsG 0.064 0.064
chsD 0.25 8
chsC chsB 0.25 4
chsC chsG 0.064 0.064
FIG 8 Pregrowing A. fumigatus in CaCl2 and CFW reduces susceptibility to
caspofungin on solid medium. Plate dilution sensitivity tests of the A. fumiga-
tus wild-type strain (H237) and various Afchs mutants on RPMI 1640 agar
supplemented with 4 g/ml caspofungin. Rows marked with an asterisk indi-
cate pregrowth of the inoculum in Sabdex broth containing 200 mM CaCl2
and 100 g/ml CFW. Plates were incubated for 24 h at 37°C. Spore numbers
per spot are 5,000, 500, 50, and 5 spores, from left to right.
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This elevation of chitin content renders C. albicans cells less sus-
ceptible to caspofungin (19). Pregrowth of A. fumigatus with
CaCl2 and CFW also resulted in an increase in chitin content,
which led to reduced susceptibility to caspofungin. This increase
in chitin content was not solely dependent on the class II, III, and
VI chitin synthase enzymes because mutants lacking enzymes
from these three classes still demonstrated an increase in chitin
content. Despite this, the AfchsG and the AfchsC AfchsG mu-
tants had no decrease in caspofungin susceptibility after treatment
with CaCl2 and CFW. Our results suggest that AfCHSG makes a
major contribution to the ability of CaCl2- and CFW-treated cells
to grow in the presence of caspofungin. Mutants lacking AfCHSG
may grow in 4g/ml caspofungin after CaCl2 and CFW treatment
compared to the other strains tested. The other Chs enzymes are
therefore likely to make some contribution to the cell wall salvage
mechanism, primed by CaCl2 and CFW treatment, because mu-
tants lacking AfCHSG still upregulated chitin production, even
though this was not sufficient to decrease sensitivity to caspofun-
gin. Therefore, increasing the cell wall chitin content is also a
mechanism of tolerance to caspofungin in filamentous fungi such
as A. fumigatus.
Here we observed that treatment with caspofungin promoted
intrahyphal growth within lysed hyphae, which may contribute to
the ability of A. fumigatus to survive caspofungin treatment. In
other filamentous fungi, intrahyphal hyphae have been proposed
to promote fungal survival in response to stress conditions (54).
Supporting this, recent work has shown that compounds which
inhibit septum formation act synergistically with caspofungin
(39). However, this is the first example of the formation of intra-
hyphal hyphae as a response to echinocandin treatment.
A. fumigatus activates a compensatory increase in chitin con-
tent in response to sub-MIC caspofungin treatment, which high-
lights the potential of combining chitin synthase inhibitors with
the echinocandins for improved and/or broader spectrum ther-
apy. In addition, the PKC, Ca2-calcineurin, and HOG signaling
pathways have been shown to be required for the response of C.
albicans and A. fumigatus to caspofungin and the in vitro paradox-
ical growth phenomenon (19–21, 55, 56). Consequently, inhibi-
tors of these pathways together with an echinocandin should be
explored as possible combination therapies.
Chitin synthase inhibitors have been shown to enhance the
activity of caspofungin and other echinocandins against a range of
fungal pathogens (19, 57–60). Combination treatment with chitin
inhibitors and the echinocandins may, therefore, add potency and
increase the spectrum of activity of echinocandins to a range of
filamentous fungal pathogens. For example, synergistic inhibition
of Alternaria infectoria with caspofungin and nikkomycin Z has
been reported (61). Combination treatment of A. fumigatus with
nikkomycin Z and the echinocandins leads to enhanced killing in
vitro and results in the formation of swollen spores with aberrant
walls, which are prone to lysis (21, 58, 62). Also, treatment with
micafungin significantly prolonged host survival in systemic and
pulmonary murine aspergillosis when combined with nikkomy-
cin Z (63, 64).
This study illuminates the conserved clinical relevance of the
cell wall compensatory mechanism in response to assaults that
weaken the wall. A common feature of this mechanism is the ac-
tivation of chitin synthesis, which involves multiple members of
fungal chitin synthase families. These pathways are activated when
fungi are exposed to sub-MIC echinocandins and may contribute
to tolerance if drugs are administered suboptimally or there is
reduced bioavailability. The ability to simultaneously block the
synthesis of chitin and -1,3-glucan represents a major opportu-
nity for future strategies to augment the range and cidality of
echinocandins.
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